Amid growing demand for GLP-1-based weight-loss drugs, Indian authorities have stepped up enforcement to prevent misuse and illegal sales. The Drugs Controller General of India, along with the Ministry of Health and Family Welfare, is conducting inspections across pharmacies, online platforms and wellness centres to ensure strict regulatory compliance. Officials have flagged serious health risks linked to unsupervised use and warned against misleading promotions and off-label usage. A nationwide advisory has already banned surrogate advertising of such drugs. With multiple audits underway, the government is reinforcing the need for prescriptions by qualified specialists and urging citizens to prioritise safe, medically guided use of these therapies.